Insider · CIK 0001802453
Roberto Bellini
Files at IKT (Inhibikase Therapeutics, Inc.). First filing Oct 23, 2024, latest Oct 23, 2024.
Roberto Bellini files SEC Form 4 as director at IKT (Inhibikase Therapeutics, Inc.). Since Oct 23, 2024, Roberto Bellini has reported 1 open-market buy worth $2.0M and 0 open-market sells worth $0, the latest filed on Oct 23, 2024.
A track record needs three past buys with six months of prices behind them; Roberto Bellini has 0, so none is measured yet.
The newest scored trade: bought $2.0M of IKT on Oct 21, 2024, filed Oct 23, 2024, scored 63 (notable).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
IKT: Inhibikase Therapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 63Notable | Inhibikase Therapeutics, Inc. | $2.0M 1,460,000 shares | - | - |
Transactions
Every row this insider has filed, 6 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 26, 2026 | IKT Inhibikase Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +155,000 | $0.00 | $0 | 155,000 | Jun 30, 2026 |
| Jun 30, 2025 | IKT Inhibikase Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +108,176 | $0.00 | $0 | 108,176 | Jul 2, 2025 |
| Feb 14, 2025 | IKT Inhibikase Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +73,580 | $0.00 | $0 | 73,580 | Feb 19, 2025 |
| Feb 14, 2025 | IKT Inhibikase Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +116,585 | $0.00 | $0 | 116,585 | Feb 19, 2025 |
| Oct 21, 2024 | IKT Inhibikase Therapeutics, Inc. | POpen-market purchase Common Stockindirect: See footnote | +1,460,000 | $1.37 | $2.0M | 1,460,000 | Oct 23, 2024 |
| Oct 21, 2024 | IKT Inhibikase Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +60,000 | $0.00 | $0 | 60,000 | Oct 23, 2024 |
Questions about Roberto Bellini
Answered from the filings on this page, as of the latest one.
Is Roberto Bellini buying or selling?
Not in the last 12 months. Roberto Bellini's latest open-market trade on SEC Form 4 was bought $2.0M of IKT on Oct 21, 2024.
How did Roberto Bellini's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Roberto Bellini has 0.
Where does Roberto Bellini file Form 4?
Roberto Bellini has filed Form 4 at IKT (Inhibikase Therapeutics, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.